Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts

Virology

Volumn 443, Issue 1, 2013, Pages 161-176

  Sami Saribas, A ^a   Abou Gharbia, Magid ^b   Childers, Wayne ^b   Sariyer, Ilker K ^a   White, Martyn K ^a   Safak, Mahmut ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Agnoprotein; BKV; DNA replication; Large T antigen; Merkel cell carcinoma virus; Polyomavirus JCV; Progressive multifocal leukoencephalopathy; Splicing; Stable dimer formation; Stable oligomer formation; SV40; Transcription

Indexed keywords

AGNOPROTEIN; DIMER; ISOLEUCINE; LEUCINE; OLIGOMER; PHENYLALANINE;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENETIC REGULATION; HUMAN; HUMAN CELL; JC VIRUS; MUTAGENESIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; RESIDUE ANALYSIS; RNA SPLICING; TRANSCRIPTION REGULATION; VIRUS CHARACTERIZATION; VIRUS TRANSCRIPTION;

AMINO ACID SUBSTITUTION; DNA MUTATIONAL ANALYSIS; HUMANS; JC VIRUS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RNA SPLICING; SEQUENCE DELETION; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

BK POLYOMAVIRUS; JC POLYOMAVIRUS; POLYOMAVIRUS;

EID: 84879782413     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.003     Document Type: Article

References (59)

1. Akan I., Sariyer I.K., Biffi R., Palermo V., Woolridge S., White M.K., Amini S., Khalili K., Safak M. Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 2006, 349(1):66-78.
2. Altschuler E. JC virus and chronic lymphocyte leukemia. J. Immunother. 1999, 22(1):90-91.
3. Alwine J.C. Evidence for simian virus 40 late transcriptional control: mixed infections of wild-type simian virus 40 and a late leader deletion mutant exhibit trans effects on late viral RNA synthesis. J. Virol. 1982, 42(3):798-803.
4. Berger J.R. The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr. Opin. Neurol. 2011, 24(3):262-267.
5. Berger J.R., Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1995, 1(1):5-18.
6. Bernacchi S., Mercenne G., Tournaire C., Marquet R., Paillart J.C. Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif. Nucleic Acids Res. 2011, 39(6):2404-2415.
7. Bourbigot S., Beltz H., Denis J., Morellet N., Roques B.P., Mely Y., Bouaziz S. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. Biochem. J. 2005, 387(Pt 2):333-341.
8. Cuesta I., Nunez-Ramirez R., Scheres S.H., Gai D., Chen X.S., Fanning E., Carazo J.M. Conformational rearrangements of SV40 large T antigen during early replication events. J. Mol. Biol. 2010, 397(5):1276-1286.
9. Cullen B.R. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 2003, 28(8):419-424.
10. Cullen B.R. Nuclear RNA export. J. Cell Sci. 2003, 116(Pt 4):587-597.
11. Darbinyan A., Darbinian N., Safak M., Radhakrishnan S., Giordano A., Khalili K. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002, 21(36):5574-5581.
12. Daugherty M.D., Booth D.S., Jayaraman B., Cheng Y., Frankel A.D. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Nat. Acad. Sci. U.S.A. 2010, 107(28):12481-12486.
13. Daugherty M.D., Liu B., Frankel A.D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 2010, 17(11):1337-1342.
14. Del Valle L., Gordon J., Enam S., Delbue S., Croul S., Abraham S., Radhakrishnan S., Assimakopoulou M., Katsetos C.D., Khalili K. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J. Nat. Cancer Inst. 2002, 94(4):267-273.
15. Dunker A.K., Cortese M.S., Romero P., Iakoucheva L.M., Uversky V.N. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 2005, 272(20):5129-5148.
16. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6(3):197-208.
17. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 2005, 15(1):35-41.
18. Foster E.C., Simmons D.T. The SV40 large T-antigen origin binding domain directly participates in DNA unwinding. Biochemistry 2010, 49(10):2087-2096.
19. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426(6968):895-899.
20. Gouttenoire J., Penin F., Moradpour D. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory. Rev. Med. Virol. 2010, 20(2):117-129.
21. Haggerty S., Walker D.L., Frisque R.J. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J. Virol. 1989, 63(5):2180-2190.
22. Hay N., Skolnik-David H., Aloni Y. Attenuation in the control of SV40 gene expression. Cell 1982, 29(1):183-193.
23. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 1967, 26(2):365-369.
24. Hoenen T., Biedenkopf N., Zielecki F., Jung S., Groseth A., Feldmann H., Becker S. Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J. Virol. 2010, 84(14):7053-7063.
25. Hou-Jong M.H., Larsen S.H., Roman A. Role of the agnoprotein in regulation of simian virus 40 replication and maturation pathways. J. Virol. 1987, 61(3):937-939.
26. Johannessen M., Myhre M.R., Dragset M., Tummler C., Moens U. Phosphorylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and has an important regulative function. Virology 2008, 379(1):97-109.
27. Johannessen M., Walquist M., Gerits N., Dragset M., Spang A., Moens U. BKV agnoprotein interacts with alpha-soluble N-ethylmaleimide-sensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP. PLoS One 2011, 6(9):e24489.
28. Johne R., Buck C.B., Allander T., Atwood W.J., Garcea R.L., Imperiale M.J., Major E.O., Ramqvist T., Norkin L.C. Taxonomical developments in the family Polyomaviridae. Arch. Virol. 2011, 156(9):1627-1634.
29. Kleinschmidt-DeMasters B.K., Tyler K.L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 2005, 353(4):369-374.
30. Langer-Gould A., Atlas S.W., Green A.J., Bollen A.W., Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 2005, 353(4):375-381.
31. Lu J.X., Sharpe S., Ghirlando R., Yau W.M., Tycko R. Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci. 2010, 19(10):1877-1896.
32. Major E.O. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 2010, 61:35-47.
33. Major E.O., Amemiya K., Tornatore C.S., Houff S.A., Berger J.R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 1992, 5(1):49-73.
34. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Nat. Acad. Sci. U.S.A. 1985, 82(4):1257-1261.
35. Margolskee R.F., Nathans D. Suppression of a VP1 mutant of simian virus 40 by missense mutations in serine codons of the viral agnogene. J. Virol. 1983, 48(2):405-409.
36. Mitchell H.K., Petersen N.S., Buzin C.H. Self-degradation of heat shock proteins. Proc. Nat. Acad. Sci. U.S.A. 1985, 82(15):4969-4973.
37. Moens U., Ludvigsen M., Van Ghelue M. Human polyomaviruses in skin diseases. Pathol. Res. Int. 2011, 2011:123491.
38. Myhre M.R., Olsen G.H., Gosert R., Hirsch H.H., Rinaldo C.H. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology 2010, 398(1):12-20.
39. Ng S.C., Mertz J.E., Sanden-Will S., Bina M. Simian virus 40 maturation in cells harboring mutants deleted in the agnogene. J. Biol. Chem. 1985, 260(2):1127-1132.
40. Okada Y., Suzuki T., Sunden Y., Orba Y., Kose S., Imamoto N., Takahashi H., Tanaka S., Hall W.W., Nagashima K., Sawa H. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep. 2005, 6(5):452-457.
41. Ou H.D., Kwiatkowski W., Deerinck T.J., Noske A., Blain K.Y., Land H.S., Soria C., Powers C.J., May A.P., Shu X., Tsien R.Y., Fitzpatrick J.A., Long J.A., Ellisman M.H., Choe S., O'Shea C.C. A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors. Cell 2012, 151(2):304-319.
42. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5(4):725-738.
43. Sadowska B., Barrucco R., Khalili K., Safak M. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J. Virol. 2003, 77(1):665-672.
44. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K., Khalili K. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 2001, 75(3):1476-1486.
45. Safak M., Khalili K. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J. Neurovirol. 2001, 7(4):288-292.
46. Safak M., Sadowska B., Barrucco R., Khalili K. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 2002, 76(8):3828-3838.
47. Saribas A.S., Arachea B.T., White M.K., Viola R.E., Safak M. Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function. Virology 2011, 420(1):51-65.
48. Saribas A.S., Ozdemir A., Lam C., Safak M. JC virus-induced progressive multifocal leukoencephalopathy. Future Virol. 2010, 5(3):313-323.
49. Saribas A.S., White M.K., Safak M. JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication. Virology 2012, 433(1):12-26.
50. Sariyer I.K., Akan I., Palermo V., Gordon J., Khalili K., Safak M. Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J. Virol. 2006, 80(8):3893-3903.
51. Sariyer I.K., Khalili K., Safak M. Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology 2008, 375(2):464-479.
52. Sariyer I.K., Saribas A.S., White M.K., Safak M. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 2011, 8(1):255.
53. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418(6898):646-650.
54. Shishido-Hara Y., Hara Y., Larson T., Yasui K., Nagashima K., and Stoner G.L. Analysis of capsid formation by human polyomavirus JC (Tokyo-1 strain) by a eucaryotic expression system: Splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly. J. Virol. 74:1840-53.
55. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W.W., Sawa H. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 2010, 6(3):e1000801.
56. Unterstab G., Gosert R., Leuenberger D., Lorentz P., Rinaldo C.H., Hirsch H.H. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010, 399(2):322-331.
57. Uversky V.N., Oldfield C.J., Dunker A.K. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recogn. 2005, 18(5):343-384.
58. Van Assche G., Van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., Verbeeck J., Geboes K., Robberecht W., Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 2005, 353(4):362-368.
59. Ziegler K., Bui T., Frisque R.J., Grandinetti A., Nerurkar V.R. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods 2004, 122(1):123-127.